Search Results

Site Search

Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody: Spencer Lodin - Insights

What started as a persistent headache for Spencer Lodin soon devolved into slowed speech, seizures, and hallucinations, symptoms which stumped ER doctors into thinking he had meningitis or was suffering from psychosis. Finally, specialized...

Gastroenterology Testing - Mayo Clinic Laboratories

All in One Place. From screening to therapeutic management, we offer a comprehensive,one-stop solution for gastroenterlogy test ordering.

Testing - Insights

Epansive clinical test menu, including more than 3,500 CAP- and CLIA-accredited tests. In addition to offering the world’s most sophisticated specialty test menu, we provide access to research-grade tests, pathology services, and sponsored...

New tests launched in December - Insights

December 2021, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Clinical microbiology at Mayo Clinic: A look back and ahead - Insights

The field of clinical microbiology has a long and distinguished history at Mayo Clinic. Since the early 1900s, the clinical microbiology team has played important and leading roles in advancing testing and patient care.

Therapeutics - Insights

Mayo Clinic Laboratories offers the industry’s most comprehensive therapeutics test menu. Developed by experts to align with governmental and professional recommendations, our assays combine cutting-edge methodologies with precision...

About Us - Insights

Mayo Clinic Laboratories isn’t just a reference lab. We’re also the diagnostic lab for a hospital, just like your lab. So we know the many benefits of keeping tests as close to patients as possible.

Hematology Testing - Mayo Clinic Laboratories

Our comprehensive test menu has beencreated to aid in the diagnosis and treatmentselection across the full spectrum of hematologicdisorders.

A comprehensive test menu explores genome for druggable targets to treat gastrointestinal cancers - Insights

Since 1992, cases of colorectal cancer have been on a slow decline, yet 52,550 people died from it in 2023. At Mayo Clinic, a cutting-edge menu of both germline (inherited genetic alterations) and somatic (tumors due to non-inherited...

Global capabilities - Insights

Check out how Mayo Clinic Laboratories optimized global capabilities facilitate individualized solutions that ensure international clients receive expeditious, accurate answers.